146 related articles for article (PubMed ID: 25184247)
21. Burkitt lymphoma after transplant: an aggressive lymphoproliferative disease.
Akar Özkan E; Özdemir BH; Akdur A; Deniz EE; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():136-8. PubMed ID: 24635811
[TBL] [Abstract][Full Text] [Related]
22. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
[TBL] [Abstract][Full Text] [Related]
23. Loads, lungs, and lymphoproliferative disorders: role of Epstein-Barr virus and limitations of what we know.
Green M; Michaels MG
Transpl Infect Dis; 2010 Aug; 12(4):281-3. PubMed ID: 20727122
[No Abstract] [Full Text] [Related]
24. Fine needle aspiration diagnosis of an early-onset post-transplant lymphoproliferative disorder.
Zhao X; Gong Y
Diagn Cytopathol; 2011 Oct; 39(10):788-90. PubMed ID: 21919218
[No Abstract] [Full Text] [Related]
25. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.
Bar-Natan M; Nagler A
Isr Med Assoc J; 2006 Mar; 8(3):205-7. PubMed ID: 16599060
[No Abstract] [Full Text] [Related]
26. Gastrointestinal Ulcerative Nodular Lesions.
Abe K; Okamura T; Isono A
Gastroenterology; 2016 Apr; 150(4):827-8. PubMed ID: 26930016
[No Abstract] [Full Text] [Related]
27. Epstein-Barr virus-associated erythema nodosum after living-donor liver transplantation: a case report.
Yokoyama S; Kasahara M; Fukuda A; Sato S; Koda F; Nakagawa A
Liver Transpl; 2009 Apr; 15(4):446-8. PubMed ID: 19326420
[No Abstract] [Full Text] [Related]
28. Role of Cytomegalovirus in the Development of Posttransplant Lymphoproliferative Disorders With or Without Epstein-Barr Virus Infection.
Namayandeh M; Jamalidoust M; Pouladfar G; Zare M; Ziyaeyan M
Exp Clin Transplant; 2022 Aug; 20(8):757-761. PubMed ID: 35037609
[TBL] [Abstract][Full Text] [Related]
29. Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
Roque J; Rios G; Humeres R; Volpi C; Herrera JM; Schultz M; Rios H; Rius M; Salgado C; Hepp J
Transplant Proc; 2006 Apr; 38(3):930-1. PubMed ID: 16647513
[TBL] [Abstract][Full Text] [Related]
30. Post-transplant lymphoproliferative disorder following cytomegalovirus reactivation in a lung recipient.
Aoyama A; Omasa M; Kondo N; Chen F; Date H; Bando T
Gen Thorac Cardiovasc Surg; 2010 May; 58(5):251-4. PubMed ID: 20449718
[TBL] [Abstract][Full Text] [Related]
31. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW
Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905
[TBL] [Abstract][Full Text] [Related]
32. Eye findings in X-linked lymphoproliferative disorder.
Nallasamy S; Eagle RC; Rorke-Adams L; Nichols KE; Brucker AJ
Retina; 2011 Apr; 31(4):790-7. PubMed ID: 21394060
[TBL] [Abstract][Full Text] [Related]
33. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070
[TBL] [Abstract][Full Text] [Related]
34. Posttransplant lymphoproliferative disorders following liver transplantation: Where are we now?
Dierickx D; Cardinaels N
World J Gastroenterol; 2015 Oct; 21(39):11034-43. PubMed ID: 26494960
[TBL] [Abstract][Full Text] [Related]
35. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
Wu JF; Ho MC; Ni YH; Chen HL; Lu CY; Hsu HY; Lee PH; Chang MH
Transplantation; 2009 Mar; 87(5):758-62. PubMed ID: 19295323
[TBL] [Abstract][Full Text] [Related]
36. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
Pinho-Apezzato ML; Tannuri U; Tannuri AC; Mello ES; Lima F; Gibelli NE; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Andrade WC; Miyatani HT
Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic application of Epstein-Barr virus-encoded RNA in situ hybridisation.
Loughrey M; Trivett M; Lade S; Murray W; Turner H; Waring P
Pathology; 2004 Aug; 36(4):301-8. PubMed ID: 15370127
[TBL] [Abstract][Full Text] [Related]
38. Heart allograft involvement with Epstein-Barr virus-associated posttransplant lymphoproliferative disorder.
Abu-Farsakh H; Cagle PT; Buffone GJ; Bruner JM; Weilbaecher D; Greenberg SD
Arch Pathol Lab Med; 1992 Jan; 116(1):93-5. PubMed ID: 1310382
[TBL] [Abstract][Full Text] [Related]
39. EBV-negative lymphoproliferative disease with hyper-IgA, in a child with combined liver and small bowel transplantation.
Robert CD; Lacaille F; Canioni D; Quartier-dit-Maire P; Talbotec C; Goulet O
Pediatr Transplant; 2004 Jun; 8(3):305-7. PubMed ID: 15176970
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus (EBV)-encoded RNA: automated in-situ hybridization (ISH) compared with manual ISH and immunohistochemistry for detection of EBV in pediatric lymphoproliferative disorders.
Fanaian NK; Cohen C; Waldrop S; Wang J; Shehata BM
Pediatr Dev Pathol; 2009; 12(3):195-9. PubMed ID: 18442302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
